Adarsh Patel
Emory University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Adarsh Patel.
Journal of Pediatric Surgery | 2016
Kristin N. Partain; Adarsh Patel; Curtis Travers; Courtney McCracken; Jonathan Loewen; Kiery Braithwaite; Kurt F. Heiss; Mehul V. Raval
INTRODUCTION Ultrasound (US) is the preferred imaging modality for evaluating appendicitis. Our purpose was to determine if including secondary signs (SS) improve diagnostic accuracy in equivocal US studies. METHODS Retrospective review identified 825 children presenting with concern for appendicitis and with a right lower quadrant (RLQ) US. Regression models identified which SS were associated with appendicitis. Test characteristics were demonstrated. RESULTS 530 patients (64%) had equivocal US reports. Of 114 (22%) patients with equivocal US undergoing CT, those with SS were more likely to have appendicitis (48.6% vs 14.6%, p<0.001). Of 172 (32%) patients with equivocal US admitted for observation, those with SS were more likely to have appendicitis (61.0% vs 33.6%, p<0.001). SS associated with appendicitis included fluid collection (adjusted odds ratio (OR) 13.3, 95% confidence interval (CI) 2.1-82.8), hyperemia (OR=2.0, 95%CI 1.5-95.5), free fluid (OR=9.8, 95%CI 3.8-25.4), and appendicolith (OR=7.9, 95%CI 1.7-37.2). Wall thickness, bowel peristalsis, and echogenic fat were not associated with appendicitis. Equivocal US that included hyperemia, a fluid collection, or an appendicolith had 96% specificity and 88% accuracy. CONCLUSION Use of SS in RLQ US assists in the diagnostic accuracy of appendicitis. SS may guide clinicians and reduce unnecessary CT and admissions.
Pacing and Clinical Electrophysiology | 2017
Anand D. Shah; Adarsh Patel; Andrea Knezevic; Michael H. Hoskins; David S. Hirsh; Faisal M. Merchant; Mikhael F. El Chami; David B. Delurgio; Anshul M. Patel; Angel R. Leon; Jonathan J. Langberg; Michael S. Lloyd
This study compared risks associated with magnetic resonance imaging (MRI) in patients with non‐MRI conditional and MRI conditional pacing and defibrillator systems with particular attention to clinically actionable outcomes.
Heart Rhythm | 2017
Faisal M. Merchant; Zachary Binney; Adarsh Patel; Jennifer Li; Lakshmi P. Peddareddy; Mikhael F. El-Chami; Angel R. Leon; Tammie E. Quest
BACKGROUND Little is known about advance directive (AD) utilization in implantable cardioverter-defibrillator (ICD) recipients. OBJECTIVE The purpose of this study was to define the prevalence and predictors of ADs in patients with ICDs. METHODS We identified ICD recipients with ADs at our institution. The primary end point was the prevalence of an AD documented up to 1 year after device implant and the secondary end point was the cumulative prevalence of an AD. RESULTS Of 2549 patients with ICDs, 701 (27.5%) were followed for at least 1 year after device implant, and of those 701 patients, 164 (23.4%) had ADs documented before or within 1 year of ICD implant. The prevalence of ICD recipients with ADs increased overtime, reaching approximately 10% in the most recent years of analysis. However, only 1 AD specifically addressed the ICD as part of end-of-life decision making. In multivariable analysis, more recent year of device implant and prior cardiovascular hospitalization were positively associated with having an AD within 1 year of implant. The cumulative prevalence of an AD at any time after implant reached about 30%, with more recent implant year, prior cardiovascular hospitalization, and palliative care consultation positively associated with the presence of an AD and black race associated with a lower cumulative prevalence. CONCLUSION In a tertiary academic medical center, most patients with ICDs still do not have ADs, and even when they do, the ICDs are rarely addressed as part of the directive. Several predictors of ADs emerged, which may provide opportunities to improve utilization of ADs in ICD recipients.
Journal of Pediatric Surgery | 2017
Kristin N. Partain; Adarsh Patel; Curtis Travers; Heather L. Short; Kiery Braithwaite; Jonathan Loewen; Kurt F. Heiss; Mehul V. Raval
OBJECTIVE Our aim was to implement a standardized US report that included secondary signs of appendicitis (SS) to facilitate accurate diagnosis of appendicitis and decrease the use of computed tomography (CT) and admissions for observation. METHODS A multidisciplinary team implemented a quality improvement (QI) intervention in the form of a standardized US report and provided stakeholders with monthly feedback. Outcomes including report compliance, CT use, and observation admissions were compared pretemplate and posttemplate. RESULTS We identified 387 patients in the pretemplate period and 483 patients in the posttemplate period. In the posttemplate period, the reporting of SS increased from 5.4% to 79.5% (p<0.001). Despite lower rates of appendix visualization (43.9% to 32.7%, p<0.001) with US, overall CT use (8.5% vs 7.0%, p=0.41) and the negative appendectomy rate remained stable (1.0% vs 1.0%, p=1.0). CT utilization for patients with an equivocal ultrasound and SS present decreased (36.4% vs 8.9%, p=0.002) and admissions for observations decreased (21.5% vs 15.3%, p=0.02). Test characteristics of RLQ US for appendicitis also improved in the posttemplate period. CONCLUSION A focused QI initiative led to high compliance rates of utilizing the standardized US report and resulted in lower CT use and fewer admissions for observation. Study of a Diagnostic Test Level of Evidence: 1.
Heart Rhythm | 2017
Mikhael F. El-Chami; Michael N. Sayegh; Adarsh Patel; Jad El-Khalil; Yaanik Desai; Angel R. Leon; Faisal M. Merchant
BACKGROUND Extraction of pacemaker and defibrillator leads in young adults may be technically challenging because of more extensive fibrosis and calcification in this patient population. OBJECTIVE The purpose of this study was to examine outcomes of lead extraction (LE) in young adults at our institution. METHODS We retrospectively identified all patients who underwent LE at our institution between January 1, 2007, and May 31, 2016. Patients were divided by age into 2 groups: <40 years (group 1, n = 84) or ≥40 years (group 2, n = 690). Outcomes were determined by medical records review. RESULTS Patients in group 2 had a higher overall average number of leads extracted per procedure compared to group 1 (1.64 ± 0.80 vs 1.45 ± 0.64; P <.001). Lead dwell time was similar in the 2 groups (5.7 ± 5 years vs 5.6 ± 4.3 years; P = .95). The younger cohort tended to require femoral extraction techniques more frequently (9.5% vs 4.4%; P = .055). Extraction procedural success (group 1: 94.1%, group 2: 94.9%; P = .792), major complications (group 1: 0%, group 2: 1.3%; P = 1), and periprocedural mortality (group 1: 0%, group 2: 0.86%; P = 1) were similar in the 2 groups. CONCLUSION LE can be performed safely and effectively in young adults. Despite the lower number of leads extracted per procedure and the similar lead dwell time, younger adults more frequently required the use of femoral extraction tools, thus highlighting the importance of performing these procedures in centers with advanced expertise in extraction techniques.
Europace | 2017
Anand D. Shah; Lakshmi P. Peddareddy; Maher A. Addish; Kimberly Kelly; Adarsh Patel; Mary Casey; Abhinav Goyal; Angel R. Leon; Mikhael F. El-Chami; Faisal M. Merchant
Aims End-stage renal disease (ESRD) increases the risk of implantable cardioverter-defibrillator (ICD) infection. We sought to define outcomes of lead extraction in patients with ESRD. Methods and results Implantable cardioverter-defibrillator lead extractions at our institution from January 2006 to March 2014 were stratified by absence (Control-Ex, n = 465) or presence (ESRD-Ex, n = 43) of ESRD. Procedural outcomes and survival were determined by medical records review. Survival in the ESRD-Ex group was compared with a contemporaneous cohort with ESRD undergoing ICD lead implantation (ESRD-I, n = 127). Among extraction patients, those with ESRD were more likely to be extracted for infection (74.4% vs. 28.6%, P < 0.001). Extraction procedure success (Control-Ex: 97% vs. ESRD-Ex: 93%, P = 0.17) and procedural deaths (Control-Ex: 1.1% vs. ESRD-Ex: 2.3%, P = 0.413) were similar. Survival 1 year following extraction was worse in the ESRD-Ex group compared with the Control-Ex, with a survival rate of 65.6% vs. 92.6% (P < 0.001); these curves continued to diverge through year 3. One-year survival in the ESRD-Ex group was worse than among ESRD patients undergoing ICD implant (ESRD-I), but these curves converged and survival was similar by year 3. Conclusions Implantable cardioverter-defibrillator lead extraction can be performed safely and effectively in patients with ESRD. However, despite high rates of procedural success, long-term mortality following extraction in ESRD patients is substantial. Much of the long-term mortality risk appears to be accounted for by the presence of ESRD and an indication for an ICD.
Heart Rhythm | 2018
Anand D. Shah; Mike A. Morris; David S. Hirsh; Megan Warnock; Yijian Huang; Michael Mollerus; Faisal M. Merchant; Anshul M. Patel; David B. Delurgio; Adarsh Patel; Michael H. Hoskins; Mikhael F. El Chami; Angel R. Leon; Jonathan J. Langberg; Michael S. Lloyd
BACKGROUND Recommendations regarding performance of magnetic resonance imaging (MRI) in non-MRI conditional pacemaker and defibrillator recipients are evolving. Previous studies have suggested low adverse event rates with MRI in nonconditional cardiac implantable electronic device (CIED) recipients, but low power limits optimal characterization of risk. OBJECTIVE The purpose of this study was to perform a systematic review and meta-analysis to characterize the clinical risk associated with MRI in CIED recipients in order to improve power. METHODS PubMed and CINAHL indexed articles from 1990 to 2017 were queried. A random effects model was used for meta-analysis of continuous variables. Safety outcomes were evaluated with descriptive statistics. RESULTS Seventy studies of non-MRI conditional devices undergoing MRI were identified, allowing for analysis of 5099 patients who underwent a total of 5908 MRI studies. Heterogeneity in lead parameter changes was observed within studies, although smaller variances were noted between studies. All lead characteristics and battery voltages showed very small, clinically insignificant changes when assessed as a pooled cohort, although cases of clinically relevant outcomes were also noted (lead failure 3, implantable cardioverter-defibrillator shock 1, electrical reset 94). Electrical resets were found only in older devices. Defibrillator function was unchanged, and inappropriate shocks were avoided with pre-MRI programming changes. CONCLUSION This review demonstrated low lead failure and clinical event rates in non-MRI conditional pacemaker and defibrillator recipients undergoing MRI. Observed changes were small and interstudy variance was low, suggesting that the composite event rates offer a reasonable estimate of true effect. The observed adverse events reinforce the need for ongoing vigilance and caution, particularly with older devices.
Pacing and Clinical Electrophysiology | 2017
Mikhael F. El-Chami; Michael N. Sayegh; Adarsh Patel; Jad El-Khalil; Yaanik Desai; Angel R. Leon; Faisal M. Merchant
Octogenarians account for a significant percentage of patients with indwelling pacemakers or defibrillators.
Heart Rhythm | 2017
Mikhael F. El-Chami; Faisal M. Merchant; Anam Waheed; Furqan Khattak; Jad El-Khalil; Adarsh Patel; Michael N. Sayegh; Yaanik Desai; Angel R. Leon; Samir Saba
Journal of the American College of Cardiology | 2016
Anand D. Shah; Lakshmi P. Peddareddy; Maher A. Addish; Kimberly Kelly; Adarsh Patel; Mary Casey; Abhinav Goyal; Angel R. Leon; Mikhael F. El-Chami; Faisal M. Merchant